GPC3 and neoplasm: In the meantime, we performed T cell proliferation experiments and found that macrophages from the miR-4510 inhibitor primary tumor successfully inhibited CD8+ T cell proliferation in vitro, and overexpression of GPC3 further induced this effect (Fig. 3G, H).